Schultes Birgit C
Insider CIK 2051419 · NTLA EVP, Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2026-03-01 | 2026-03-03 | 56,000 | — | $0 | 56,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2026-03-01 | 2026-03-03 | 39,200 | — | $0 | 137,733 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2026-01-05 | 2026-01-07 | 8,508 | $9.21 | $78.4K | 98,533 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2025-10-01 | 2025-10-03 | 31 | $17.38 | $539 | 105,184 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2025-03-01 | 2025-03-04 | 53,714 | — | $0 | 53,714 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2025-03-01 | 2025-03-04 | 37,600 | — | $0 | 105,215 | SEC↗ |